EARLY REAL-WORLD EXPERIENCE WITH ABRILADA WITHIN THE CANADIAN PATIENT POPULATION

被引:0
|
作者
Ling, Y. L. [1 ]
Wicker, A. [2 ]
Gruben, D. [2 ]
Pollock, R. A. [3 ]
Houle, G. [4 ]
Jayakumar, M. K. [4 ]
Tehrani, A. [4 ]
Latymer, M. [5 ]
机构
[1] Pfizer Inc, New York, NY USA
[2] Pfizer Inc, Collegeville, PA USA
[3] Pfizer Canada, Kirkland, PQ, Canada
[4] IQVIA, Kirkland, PQ, Canada
[5] Pfizer Ltd, Sandwich, Kent, England
关键词
D O I
暂无
中图分类号
F [经济];
学科分类号
02 ;
摘要
PCR52
引用
收藏
页码:S305 / S305
页数:1
相关论文
共 50 条
  • [31] Use of Rituximab in Severe Rheumatoid Arthritis: "Real-World" Experience in a Canadian Center
    Hazlewood, Glen
    Barnabe, Cheryl
    Barr, Susan
    Martin, Liam
    ARTHRITIS AND RHEUMATISM, 2008, 58 (12): : 4014 - 4014
  • [32] Real-World Experience with Ofatumumab
    Thomas, K.
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 202 - 203
  • [33] Real-world experience - Reply
    Hutchinson, D
    CHEMICAL ENGINEERING PROGRESS, 1998, 94 (03) : 8 - 8
  • [34] Real-World Experience with Ocrelizumab
    Moss, Brandon P.
    Utigard, Erica
    Baldassari, Laura E.
    Cohen, Jeffrey A.
    Ontaneda, Daniel D.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 69 - 70
  • [35] Real-world experience with ocrelizumab
    Moss, B.
    Parrotta, E.
    Baldassari, L.
    Planchon, S.
    Cohen, J.
    Ontaneda, D.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 780 - 781
  • [36] Real-World Experience of Clascoterone Cream 1% in Acne Management: Case Series and Canadian Experience
    Tay, Elena
    Loo, Wei Jing
    CLINICAL COSMETIC AND INVESTIGATIONAL DERMATOLOGY, 2025, 18 : 161 - 167
  • [37] Real-World Experience with Ocrelizumab
    Moss, Brandon P.
    Utigard, Erica
    Baldassari, Laura E.
    Cohen, Jeffrey A.
    Ontaneda, Daniel D.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 31 - 31
  • [38] Ocrelizumab real-world experience
    Moss, B.
    Utigard, E.
    Baldassari, L.
    Cohen, J.
    Ontaneda, D.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 504 - 505
  • [39] Real-world experience of apremilast
    Fremlin, G. A.
    Bedlow, A.
    BRITISH JOURNAL OF DERMATOLOGY, 2017, 177 : 63 - 63
  • [40] Real-World Experience with Ocrelizumab
    Moss, Brandon
    Parrotta, Erica
    Baldassari, Laura
    Cohen, Jeffrey
    Ontaneda, Daniel
    NEUROLOGY, 2019, 92 (15)